CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −7,845 | $37.04 | $291K | 331,059 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −4,465 | $36.00 | $161K | 326,594 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −8,972 | $36.99 | $332K | 317,622 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −18 | $37.54 | $676 | 317,604 |
| 2026-07-15 | Hanson Kristopher General Counsel | Sale | −2,147 | $36.00 | $77K | 160,184 |
| 2026-07-15 | Hanson Kristopher General Counsel | Sale | −5,103 | $36.99 | $189K | 155,081 |
| 2026-07-15 | Hanson Kristopher General Counsel | Sale | −10 | $37.54 | $375 | 155,071 |
| 2026-07-15 | Lillie James Woodruff Chief Scientific Officer | Sale | −2,238 | $36.00 | $81K | 240,491 |
| 2026-07-15 | Lillie James Woodruff Chief Scientific Officer | Sale | −5,393 | $36.99 | $199K | 235,098 |
| 2026-07-15 | Lillie James Woodruff Chief Scientific Officer | Sale | −12 | $37.54 | $450 | 235,086 |
| 2026-07-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −18,950 | $36.00 | $682K | 1,375,144 |
| 2026-07-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −42,738 | $36.99 | $1.6M | 1,332,406 |
| 2026-07-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −90 | $37.54 | $3K | 1,332,316 |
| 2026-06-23 | Luneborg Nanna Liebach Director | Grant or award | +3,932 | 3,932 | ||
| 2026-06-23 | Luneborg Nanna Liebach Director | Grant or award · Stock Option (right to buy) | +14,902 | 14,902 | ||
| 2026-06-23 | Garnett Timothy John Director | Grant or award | +3,932 | 53,457 | ||
| 2026-06-23 | Garnett Timothy John Director | Grant or award · Stock Option (right to buy) | +14,902 | 14,902 | ||
| 2026-06-23 | Walker Maria C Director | Grant or award | +3,932 | 62,703 | ||
| 2026-06-23 | Walker Maria C Director | Grant or award · Stock Option (right to buy) | +14,902 | 14,902 | ||
| 2026-06-23 | Cox Troy Director | Grant or award | +7,864 | 7,864 |
Page 4 of 12 · 239 trades